Revelation Biosciences, Inc. SEC filings REVB
Revelation Biosciences, Inc. has 389 filings in SEC EDGAR's recent list, going back to May 14, 2020. Its latest annual report, Form ARS, was filed on May 11, 2026 for the period ended May 11, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 19, 2026 | Aug 17, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Jul 13, 2026 | Jul 10, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 24, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Other events
|
Jun 1, 2026 | Jun 1, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Change to shareholder rights, Shareholder vote results
|
Mar 19, 2026 | Mar 18, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Nov 6, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights
|
Jan 29, 2026 | Jan 26, 2026 |
| 8-K |
Current report
Other events
|
Jan 22, 2026 | Jan 21, 2026 |
| 8-K |
Current report
Change to shareholder rights, Shareholder vote results, Other events
|
Dec 3, 2025 | Dec 3, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 29, 2025 | Oct 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 15, 2025 | Oct 15, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Other events
|
Sep 15, 2025 | Sep 11, 2025 |
| 8-K |
Current report
Other events
|
Sep 9, 2025 | Sep 9, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2025 | Aug 8, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jul 9, 2025 | Jul 7, 2025 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 25, 2025 | Jun 23, 2025 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Other events
|
Jun 4, 2025 | May 28, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
May 28, 2025 | May 23, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Other events
|
Mar 17, 2025 | Mar 17, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2025 | Mar 6, 2025 |
| 8-K |
Current report
Other events
|
Feb 24, 2025 | Feb 19, 2025 |
| 8-K |
Current report
Other events
|
Feb 11, 2025 | Feb 10, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jan 30, 2025 | Jan 28, 2025 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jan 21, 2025 | Jan 17, 2025 |
| 8-K |
Current report
Listing notice, Other events
|
Jan 7, 2025 | Jan 3, 2025 |
| 8-K |
Current report
Other events
|
Dec 12, 2024 | Dec 12, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Other events
|
Dec 6, 2024 | Dec 3, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2024 | Nov 8, 2024 |
| 8-K |
Current report
Listing notice
|
Oct 21, 2024 | Oct 16, 2024 |
| 8-K |
Current report
Other events
|
Sep 27, 2024 | Sep 24, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Other events
|
Aug 26, 2024 | Aug 21, 2024 |
| 8-K |
Current report
Listing notice
|
Aug 19, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2024 | Aug 9, 2024 |
| 8-K |
Current report
Other events
|
Aug 2, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Other events
|
Jun 24, 2024 | Jun 24, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 16, 2024 | May 15, 2024 |
| 8-K |
Current report
Results of operations
|
May 10, 2024 | May 10, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 22, 2024 | Mar 22, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 12, 2024 | Mar 12, 2024 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Other events
|
Feb 8, 2024 | Feb 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 30, 2024 | Jan 30, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jan 23, 2024 | Jan 22, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jan 22, 2024 | Jan 17, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 12, 2023 | Oct 12, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 2, 2023 | Sep 27, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2023 | Aug 11, 2023 |
| 8-K |
Current report
Listing notice
|
Aug 11, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jul 14, 2023 | Jul 14, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 7, 2023 | Jul 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 29, 2023 | Jun 29, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 12, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 25, 2023 | May 25, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 22, 2023 | May 22, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 3, 2023 | Mar 30, 2023 |
| 8-K |
Current report
Other events
|
Feb 17, 2023 | Feb 16, 2023 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Regulation FD disclosure
|
Feb 13, 2023 | Feb 9, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
Jan 31, 2023 | Jan 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Other events
|
Jan 10, 2023 | Jan 10, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
|
Dec 21, 2022 | Dec 19, 2022 |
| 8-K |
Current report
Listing notice
|
Dec 12, 2022 | Dec 6, 2022 |
| 8-K |
Current report
Listing notice
|
Nov 25, 2022 | Nov 23, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 25, 2022 | Oct 25, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 6, 2022 | Oct 6, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 17, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 1, 2022 | Jul 28, 2022 |
| 8-K |
Current report
Listing notice
|
Jun 10, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Listing notice
|
May 31, 2022 | May 24, 2022 |
| 8-K |
Current report
Results of operations
|
May 17, 2022 | May 16, 2022 |
| 8-K |
Current report
Auditor change
|
May 6, 2022 | May 2, 2022 |
| 8-K/A | Amended current report | Apr 22, 2022 | Jan 10, 2022 |
| 8-K/A | Amended current report | Apr 15, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 15, 2022 | Mar 15, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 11, 2022 | Feb 9, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jan 27, 2022 | Jan 23, 2022 |
| 8-K |
Current report
Acquisition or sale of assets, Unregistered share sale, Change in control, Officer or director change, Bylaw or fiscal year change
|
Jan 14, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2022 | Jan 11, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jan 12, 2022 | Jan 6, 2022 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure, Other events
|
Dec 23, 2021 | Dec 21, 2021 |
| 8-K |
Current report
Other events
|
Dec 17, 2021 | Dec 13, 2021 |
| 8-K |
Current report
Other events
|
Nov 24, 2021 | Nov 13, 2021 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Oct 19, 2021 | Oct 13, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
Oct 13, 2021 | Oct 8, 2021 |
| 8-K |
Current report
Material agreement, New debt, Bylaw or fiscal year change, Other events
|
Sep 23, 2021 | Sep 17, 2021 |
| 8-K |
Current report
Material agreement
|
Sep 2, 2021 | Aug 29, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 31, 2021 | Aug 31, 2021 |
| 8-K |
Current report
Restatement
|
Jun 16, 2021 | Jun 15, 2021 |
| 8-K |
Current report
Listing notice, Other events
|
Jun 1, 2021 | May 28, 2021 |
| 8-K/A |
Amended current report
Officer or director change
|
Mar 5, 2021 | Feb 8, 2021 |
| 8-K |
Current report
Officer or director change
|
Feb 23, 2021 | Feb 19, 2021 |
| 8-K |
Current report
Other events
|
Nov 10, 2020 | Nov 10, 2020 |
| 8-K |
Current report
Material agreement
|
Oct 19, 2020 | Oct 13, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Oct 13, 2020 | Oct 7, 2020 |
Showing 100 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- REVB (Nasdaq), REVBW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1810560
- Former names
- Petra Acquisition Inc. (until Jan 11, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.